Normal cells become cancerous through a set of steps that result in the continuous activity of signaling pathways that stimulate their multiplication and dissemination to other sites in the organism. […]
Hirshberg Foundation for Pancreatic Cancer Research Announces the 2012-2013 Seed Grant Award Recipients
Final Media Contact: Donald Wilson (310) 899-2900 dwilson@mcraigassociates.com THE HIRSHBERG FOUNDATION FOR PANCREATIC CANCER RESEARCH ANNOUNCES THE 2012-2013 SEED GRANT AWARD RECIPIENTS LOS ANGELES, Calif., – (November 1, 2012) – […]
Hirshberg Researcher Receives New Grant for $10 Million!
We are pleased to announce that Guido Eibl, M.D., Principal Investigator and Scientific Director of the Ronald S. Hirshberg Translational Pancreatic Cancer Research Laboratory at the UCLA School of Medicine, […]
UCLA study pinpoints types of bacteria in saliva associated with pancreatic cancer
By Rachel Champeau October 13, 2011 UCLA RESEARCH ALERT FINDINGS: A UCLA study has found variations in the types of bacteria found in the saliva of patients with pancreatic […]
Metformin continues to prove viability
Type 2 diabetes increases and metformin reduces total, colorectal, liver and pancreatic cancer incidences in Taiwanese: a representative population prospective cohort study of 800,000 individuals Download PDF release Metformin pilot […]
Pancreatic cancer, targeted drugs in comparison with phytochemicals
Link to the full article at springerlink Download .pdf Abstract Diverse mechanisms of growth inhibition by luteolin, resveratrol, and quercetin in MIA PaCa-2 cells: a comparative glucose tracer study with […]